Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists
作者:Guo-Hua Chu、Christopher T. Saeui、Karin Worm、Damian G. Weaver、Allan J. Goodman、Robert L. Broadrup、Joel A. Cassel、Robert N. DeHaven、Christopher J. LaBuda、Michael Koblish、Bernice Brogdon、Steve Smith、Bertrand Le Bourdonnec、Roland E. Dolle
DOI:10.1016/j.bmcl.2009.08.063
日期:2009.10
Replacement of the phenyl ring in our previous (morpholinomethyl)aniline carboxamide cannabinoid receptor ligands with a pyridine ring led to the discovery of a novel chemical series of CB2 ligands. Compound 3, that is, 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide was identified as a potent and selective CB2 agonist exhibiting in vivo efficacy after oral administration in a
用吡啶环取代我们以前的(吗啉代甲基)苯胺羧酰胺大麻素受体配体中的苯环,导致发现了新的化学系列CB 2配体。化合物3(即2,2-二甲基-N-(5-甲基-4-(吗啉代甲基)吡啶基-2-基)丁酰胺)被确定为有效和选择性的CB 2激动剂,口服后在体内给药。神经性疼痛的大鼠模型。